Eczema

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Evidencing Vibroacoustic Sensing for Inflammatory Skin Disease Monitoring

Effects of Treatments on Atopic Dermatitis

Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

The Impact of Dietary Salt on the Severity of Eczema

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

Cardamom and Topical Roseomonas in Atopic Dermatitis

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies

Efficacy of Topical Cannabidiol for Eczema

Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema

A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis